Imunon, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Imunon, Inc. (IMNN) on July 21, 2025. The filing reports a material corporate action approved by stockholders on July 11, 2025, and filed with the Delaware Secretary of State on July 21, 2025.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a capital structure adjustment.
Material Changes
- Reverse Stock Split: The Company implemented a one-for-fifteen (1-for-15) reverse stock split of its outstanding common stock.
- Effective Date: The split became effective on July 25, 2025, at 12:01 a.m. Eastern Time.
- Share Count Reduction: The number of outstanding shares was reduced from approximately 31.8 million to approximately 2.1 million.
- Trading Details: Post-split shares began trading on the Nasdaq Capital Market under the existing ticker symbol "IMNN" with a new CUSIP number (15117N701).
- Fractional Shares: No fractional shares were issued; stockholders entitled to a fractional share received one full share instead.
- Registration Statements: Undistributed shares in active S-1, S-3, and S-8 registration statements were proportionately reduced to reflect the split.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the description of the amendment is qualified by the full text of the Certificate of Amendment filed as Exhibit 3.1.
Key Facts for Investor Verification
- Verify the new CUSIP number (15117N701) for post-split trading.
- Confirm the adjusted share count in brokerage accounts following the July 25, 2025 effective time.
- Note that the par value ($0.01) and authorized share count remain unchanged.
- Review the press release dated July 23, 2025 (Exhibit 99.1) for additional context on the split rationale.